Merger talks between Care New England, one of the largest healthcare systems in Rhode Island, Brown University and Lifespan, operator of Rhode Island Hospital, are over.
In regions of the world lacking resources to conduct comprehensive autopsies, AI can automatically draw cause-of-death conclusions from verbalized clues.
AHRA 2019, the annual meeting of AHRA: The Association for Medical Imaging Management, begins in just a few short days. It’s time to pack those bags and finalize that schedule!
After looking at more than 12,500 preventative office visits included in the National Ambulatory Medical Care Survey, researchers reported that the rate of screening breast ultrasound ordering by physicians has remained low.
High-sensitivity cardiac troponin I assays, when considered in the context of appropriate thresholds, can identify and expedite triage of patients at varying levels of risk for myocardial infarction, a JACC study found.
The American College of Radiology (ACR) has expressed “serious concerns” with the No Surprises Act— legislation geared toward ending surprise medical bills, in a July 16 statement.
Massachusetts-based Azurity Pharmaceuticals announced July 10 it had received FDA approval for Katerzia Oral Suspension, making the drug the first and only FDA-approved amlodipine oral suspension to hit the commercial market.
Reps. Scott Peters, Bobby L. Rush and George Holding introduced a bipartisan bill this week that would increase patient access to key diagnostic radiopharmaceuticals used to help treat Alzheimer’s disease, Parkinson’s disease and numerous cancers.
Clinical decision support (CDS) tools can improve the appropriateness scores of advanced imaging orders when used in clinical practice, according to a single-center analysis published in the American Journal of Roentgenology.
A study of more than a quarter of a million heart patients in Canada has revealed statins are “significantly” underutilized to treat lipid abnormalities in individuals with and at risk for ASCVD.
